PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials. [electronic resource]
Producer: 20200327Description: e618-e626 p. digitalISSN:- 1938-0682
- Antineoplastic Agents, Immunological -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- B7-H1 Antigen -- antagonists & inhibitors
- Carcinoma, Transitional Cell -- drug therapy
- Clinical Trials as Topic
- Humans
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Survival Analysis
- Treatment Outcome
- Tumor Microenvironment -- drug effects
- Urologic Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.